Legend Biotech Corporation
IPOIn pursuit of cures.
Public · Somerset, United States · Founded 2014 · $150.5M raised
- Headquarters
- Somerset, New Jersey
- Employees
- 1001–5000
- Founded
- 2014
- Business Model
- B2B
- Website
- legendbiotech.com
- Total Funding
- $150.5M
- Last Round
- $150.5M Series AApr 2020
- Rounds
- 1
- Type
- Public
About
Legend Biotech is a global commercial-stage biotechnology company focused on cell and gene therapies. Co-developed CARVYKTI (cilta-cel) CAR-T for multiple myeloma with Janssen.
Summary
Legend Biotech Corporation is a Biotech company based in Somerset, United States, founded in 2014. It has raised $150.5M in total across 1 round, most recently a $150.5M Series A round in Apr 2020. Investors include Hudson Bay Capital Management, Lilly Asia Ventures and Vivo Capital.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Apr 2020
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...